Journal of Business Ethics 77 (1):33 - 44 (2008)
AbstractPublic discussions of ethical issues related to the biotechnology industry tend to treat “biotechnology” as a single, undifferentiated technology. Similarly, the pros and cons associated with this entire sector tend to get lumped together, such that individuals and groups often situate themselves as either “pro-” or “anti-” biotechnology as a whole. But different biotechnologies and their particular application context pose very different challenges for ethical corporate decision-making. Even within a single product category, different specialty products can pose strikingly different ethical challenges. In this paper, we focus on the single over-arching category of “genetic testing” and compare tests for disease susceptibility and drug response. We highlight the diversity of ethical challenges – grouped under the broad categories of “truth in advertising” and “protecting intellectual property” – raised by the commercialization and marketing of these technologies. By examining social and technical differences between genetic tests, and the associated corporate ethics challenges posed by their commercialization, our intent is to contribute to the nascent business ethics literature examining issues raised by the development and marketing of genetic tests.
Similar books and articles
Genetic Tests in the Insurance System: Criteria for a Moral Evaluation.Felix Thiele - 2003 - Poiesis and Praxis 1 (3):185-195.
Explicating Ethical Corporate Marketing. Insights From the BP Deepwater Horizon Catastrophe: The Ethical Brand That Exploded and Then Imploded. [REVIEW]John M. T. Balmer, Shaun M. Powell & Stephen A. Greyser - 2011 - Journal of Business Ethics 102 (1):1-14.
The Ethical Challenges of Direct-to-Consumer Genetic Testing.Cheryl Berg & Kelly Fryer-Edwards - 2008 - Journal of Business Ethics 77 (1):17 - 31.
Future Directions in Genetic Counseling: Practical and Ethical Considerations.Barabara Biesecker - 1998 - Kennedy Institute of Ethics Journal 8 (2):145-160.
Commercial Genetic Testing in Mainland China: Social, Financial and Ethical Issues. [REVIEW]Suli Sui & Margaret Sleeboom-Faulkner - 2007 - Journal of Bioethical Inquiry 4 (3):229-237.
Marketing of Harmful Products.Laura Radulian - 2005 - International Corporate Responsibility Series 2:329-357.
Are Genetic Self-Tests Dangerous? Assessing the Commercialization of Genetic Testing in Terms of Personal Autonomy.Ludvig Beckman - 2004 - Theoretical Medicine and Bioethics 25 (5-6):387-398.
Added to PP
Historical graph of downloads
Citations of this work
A Tidal Wave of Inevitable Data? Assetization in the Consumer Genomics Testing Industry.Nicole Gross & Susi Geiger - 2021 - Business and Society 60 (3):614-649.
The Moral Limits of the Market: Science Commercialization and Religious Traditions.Jared L. Peifer, David R. Johnson & Elaine Howard Ecklund - 2019 - Journal of Business Ethics 157 (1):183-197.
References found in this work
Prenatal Diagnosis and Discrimination Against the Disabled.L. Gillam - 1999 - Journal of Medical Ethics 25 (2):163-171.
Ethics and Genetics: Susceptibility Testing in the Workplace. [REVIEW]Chris MacDonald & Bryn Williams-Jones - 2002 - Journal of Business Ethics 35 (3):235 - 241.
The Natural Father: Genetic Paternity Testing, Marriage, and Fatherhood.Gregory E. Kaebnick - 2004 - Cambridge Quarterly of Healthcare Ethics 13 (1):49-60.
Social Contract Theory and Just Decision Making: Lessons From Genetic Testing for the BRCA Mutations.Bryn Williams-Jones & Michael M. Burgess - 2004 - Kennedy Institute of Ethics Journal 14 (2):115-142.